Literature DB >> 6759233

Insulin and multiplication stimulating activity (an insulin-like growth factor) stimulate islet (beta-cell replication in neonatal rat pancreatic monolayer cultures.

A Rabinovitch, C Quigley, T Russell, Y Patel, D H Mintz.   

Abstract

A possible role for insulin in stimulating islet beta-cell replication was examined in neonatal rat pancreatic monolayer cultures. Addition of insulin to serum-free medium increased the mitotic index and stimulated dose-dependent increases in [3H]-thymidine incorporation in nuclei of islet beta-cells in aldehyde-thionine-stained autoradiographs. The effects of insulin were not associated with any significant changes in glucagon or somatostatin levels in the culture media. Multiplication stimulating activity (MSA), an insulin-like growth factor, was about 100-fold more potent than insulin: 3 ng/ml MSA stimulated a half-maximal increase in thymidine labeling of beta-cell (+63%, P less than 0.005), whereas 300 ng/ml insulin was required for a similar effect. The maximal effects of insulin and MSA were similar, and the combination of maximal stimulatory concentrations of MSA (30 ng/ml) and insulin (3000 ng/ml) was not more effective than either substance added alone, suggesting that both peptides act on the same mechanism(s) regulating beta-cell replication. Furthermore, an antibody to the insulin receptor did not prevent the stimulatory effects of either insulin or MSA on thymidine labeling of beta-cells. These results demonstrate that insulin can stimulate islet beta-cell replication directly, possibly through a receptor for MSA or another insulin-like growth factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6759233     DOI: 10.2337/diab.31.2.160

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  18 in total

1.  Culture of endocrine pancreatic cells in protein-free, chemically defined media.

Authors:  F Kinard; L De Clercq; B Billen; B Amory; J J Hoet; C Remacle
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

Review 2.  Pancreatic beta-cell growth and diabetes mellitus.

Authors:  I Swenne
Journal:  Diabetologia       Date:  1992-03       Impact factor: 10.122

3.  Decreased alpha1-adrenergic receptor binding in the cerebral cortex and brain stem during pancreatic regeneration in rats.

Authors:  V Ani Das; B Savitha; C S Paulose
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

Review 4.  Somatomedins: chemical and functional characteristics of the different molecular forms.

Authors:  A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1989-04       Impact factor: 4.256

5.  Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans.

Authors:  J J Meier; A E Butler; R Galasso; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2006-09-23       Impact factor: 10.122

6.  Glucocorticoids stimulate the division of rat pancreatic islet tumour cells in tissue culture.

Authors:  G Brons; A C Newby; C N Hales
Journal:  Diabetologia       Date:  1984-11       Impact factor: 10.122

Review 7.  Channeling dysglycemia: ion-channel variations perturbing glucose homeostasis.

Authors:  Jerod Scott Denton; David Aaron Jacobson
Journal:  Trends Endocrinol Metab       Date:  2011-11-29       Impact factor: 12.015

8.  Replication of adult pancreatic-beta cells cultured on bovine corneal endothelial cell extracellular matrix.

Authors:  G T Schuppin; S Bonner-Weir; E Montana; N Kaiser; G C Weir
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-04       Impact factor: 2.416

9.  The influence of hyperglycaemia, hyperinsulinaemia and genetic background on the fate of intrasplenically implanted mouse islets.

Authors:  A Andersson
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

10.  IGF-I overexpression does not promote compensatory islet cell growth in diet-induced obesity.

Authors:  Katie Robertson; Jing Dong; Kristine De Jesus; Jun-Li Liu
Journal:  Endocrine       Date:  2009-10-30       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.